Skip to main content
Fig. 3 | Radiation Oncology

Fig. 3

From: Activity-based cost analysis of hepatic tumor ablation using CT-guided high-dose rate brachytherapy or CT-guided radiofrequency ablation in hepatocellular carcinoma

Fig. 3

Results of a sensitivity analysis comparing costs of CT-HDRBT and CT-RFA in relation to the number of patients treated with either method per year. The break-even is reached at 55 treated patients per year, when calculated costs of CT-HDRBT fall below the costs of CT-RFA. At this point, calculated costs for CT-RFA are 1,841.92 € and 1,827.89 € for CT-HDRBT, and costs for CT-HDRBT decrease further as the number of treated patients increases, whereas costs for CT-RFA remain nearly stable

Back to article page